Growing teratoma syndrome vs. chemotherapeutic retroconversion case report and review of the literature

被引:52
作者
Amsalem, H
Nadjari, M
Prus, D
Hiller, N
Benshushan, A
机构
[1] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91240 Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Pathol, IL-91240 Jerusalem, Israel
[3] Hadassah Univ Hosp, Dept Radiol, IL-91240 Jerusalem, Israel
关键词
GCT teratoma; chemotherapeutic retroconversion;
D O I
10.1016/j.ygyno.2003.10.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Immature ovarian teratoma is the third most common germ cell tumor (GCT) following dysgerminoma and endodermal sinus tumor. The treatment of choice during childbearing age for immature teratoma composes of unilateral oophorectomy and in case of metastatic disease postoperative chemotherapy (BEP). Finding a solid mass in the peritoneal or chest cavity during routine follow up raises the suspicion of distance recurrence. DiSaia was the first to describe the appearance of benign distant metastasis during routine follow up. He termed this phenomenon "chemotherapeutic retroconversion". Latter, Logothetis described what seems to be a similar phenomenon in testicular non-seminomatous germ cell tumor (NSGCT) that he called the "growing teratoma syndrome". Case. We present a case of a 12-year-old girl treated for growing teratoma syndrome after primary ovarian GCT. Conclusion. Review of the literature shows that this syndrome and the "chemotherapeutic retroconversion" are probably the same phenomenon. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:357 / 360
页数:4
相关论文
共 17 条
[1]  
AHLGREN AD, 1984, CANCER, V54, P2015, DOI 10.1002/1097-0142(19841101)54:9<2015::AID-CNCR2820540939>3.0.CO
[2]  
2-B
[3]   The growing teratoma syndrome:: results of therapy and long-term follow-up of 33 patients [J].
André, F ;
Fizazi, K ;
Culine, S ;
Droz, JP ;
Taupin, P ;
Lhommé, C ;
Terrier-Lacombe, MJ ;
Théodore, C .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1389-1394
[4]   RETROCONVERSION OF MALIGNANT IMMATURE TERATOMAS OF THE OVARY AFTER CHEMOTHERAPY [J].
ARONOWITZ, J ;
ESTRADA, R ;
LYNCH, R ;
KAPLAN, AL .
GYNECOLOGIC ONCOLOGY, 1983, 16 (03) :414-421
[5]   Tumor chemoconversion following surgery, chemotherapy, and normalization of serum tumor markers in a woman with a mixed type germ cell ovarian tumor [J].
Ben David, Y ;
Weiss, A ;
Shechtman, L ;
Shalev, E .
GYNECOLOGIC ONCOLOGY, 2002, 84 (03) :464-467
[6]  
DISAIA PJ, 1977, OBSTET GYNECOL, V49, P346
[7]  
Geisler John P., 1994, Obstetrics and Gynecology, V84, P719
[8]  
HONG WK, 1977, CANCER, V40, P2987, DOI 10.1002/1097-0142(197712)40:6<2987::AID-CNCR2820400634>3.0.CO
[9]  
2-A
[10]   Growing teratoma syndrome after chemotherapy for a mixed germ cell tumor of the ovary [J].
Itani, Y ;
Kawa, M ;
Toyoda, S ;
Yamagami, K ;
Hiraoka, K .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2002, 28 (03) :166-171